IRE ELiT and PI Medical Diagnostic Equipment announce commercial partnership for Galli Ad generator in the Netherlands and Flanders

Fleurus (Belgium) and Raamsdonksveer (The Netherlands) – . IRE ELiT & PI Medical Diagnostic Equipment enters into a commercial partnership to promote and market the Germanium-68 / Gallium-68 generator, Galli Ad, indicated for in vitro radiolabeling of radiopharmaceutical kits and preparation developed for positron emission tomography (PET) imaging.

IRE ELiT is already established with its generator in the Netherlands and Flanders since obtaining its Marketing Authorization in 2018. Until now, IRE ELiT has dealt directly with customers, but it has decided to move closer to its customers by offering local and technical proximity thanks to its partnership with PI Medical, thereby guaranteeing a high quality of service and expertise.

For IRE Elit, the quality of service to our customers is an integral part of the quality of our products. We are particularly glad to set this partnership with P.I. Medical Diagnostic Equipment. The reputation and professionalism of its team is a strong asset for us, especially to support the development of Galli Ad, in this region where nuclear medicine teams are among the best in Europe”, said Jean Bonnet, Head of Strategy, Sales and Marketing.
As PI Medical, we were very honored and flattered when IRE ELiT contacted us. Our main focus of the company is providing service and high-quality products to our customers. The products of IRE EliT are a perfect addition to our portfolio. We look forward to help IRE EliT to extend their market in The Netherlands and Flanders”, explained Peter Liedorp, Managing Director.

About IRE ELiT

IRE ELiT, the innovation subsidiary of IRE, is a radiopharmaceutical company founded in 2010 to fully develop radiopharmaceuticals used in molecular imaging and therapy. IRE ELiT works closely with its clients in a «test & learn» spirit as well as with globally recognized universities and research centers. Today, IRE ELiT is one of only two global suppliers of germanium-68 (Ge-68)/gallium-68 (Ga-68) generators approved for use as a drug in Europe and as an active pharmaceutical ingredient (API) in the U.S. IRE and IRE ELiT currently employ 250 people. More information is available at www.ire.com

About PI Medical Diagnostic Equipment

PI Medical Diagnostic Equipment B.V. was founded in 1995. The company has always been a distributor for mostly the BeNeLux countries. In the past the company was mainly focused on equipment in Nuclear Medicine and Radiotherapy. In 2018 Peter Liedorp and John Danklof took over the company. From that point PI Medical started to change and focus mainly on Medical Imaging. We started many processes to professionalize the company. At this moment we fulfill all regulatory needs so we can do what we like the most, offering the best solutions to our customers.
PI Medical employ 12 people now. Most of them worked in the hospital on a Nuclear Medicine department and/or Radiology department. Please find more information on our brand-new website: www.pi-medical.nl

About Gallium-68

Gallium-68 is the isotope which, when accompanied by a cold vector, is used in oncology for the diagnosis of neuroendocrine cancers, particularly difficult to detect at the early stage, and for the diagnosis of prostate cancer (recurrent forms), the most common cancer in men. It is also used in clinical development for other promising indications.

Bérénice Pignol

IRE - IRE ELiT

 

 

 

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About IRE and IRE ELiT

About IRE

The Institute for Radioelements (IRE) is a public utility foundation primarily focused on producing radioisotopes for diagnostic and therapeutic applications in nuclear medicine. IRE is the global leader in Molybdenum-99 production, the parent isotope of metastable Technetium-99m, the most widely used isotope in nuclear medicine for various examinations (heart, bones, lungs, thyroid, brain, kidneys, etc.). Beyond its production activities, IRE contributes to environmental protection and monitoring through its IRE Lab division, offering services such as radioactivity measurement in various samples, radiological characterization of waste and contaminated materials, and consultancy and technical support in radiological and nuclear fields.

IRE ELiT, the innovation subsidiary founded in 2010, develops radiopharmaceuticals for cancer imaging and treatment. Together, IRE and IRE ELiT employ more than 270 people. More information: www.ire.eu

 

 

Contact

www.ire.eu